Takahiro Akioka

Miyazaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Bladder Perforation Following Transurethral Resection of Bladder Tumor With Immediate Intravesical Instillation of Epirubicin.

Bladder Perforation Following Transurethral Resection of Bladder Tumor With Immediate Intravesical Instillation of Epirubicin.

Journal: IJU case reports

Published: June 05, 2026

Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review.

Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review.

Journal: International journal of clinical oncology

Published: December 14, 2025

Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells.

Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells.

Journal: Biomedicines

Published: February 26, 2025

Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy.

Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy.

Journal: Biomedicines

Published: February 20, 2025

Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC.

Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC.

Journal: International journal of molecular sciences

Published: February 04, 2025

Bilateral long ureteral strictures were successfully replaced by ileum in inverse seven configuration: A case report.

Bilateral long ureteral strictures were successfully replaced by ileum in inverse seven configuration: A case report.

Journal: International journal of surgery case reports

Published: December 21, 2023

Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice.

Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice.

Journal: Human cell

Published: November 24, 2022

A Cohort Study on the Prognosis of Patients with Urothelial Carcinoma Using the Miyazaki Urological Cancer Database (MUCD)

A Cohort Study on the Prognosis of Patients with Urothelial Carcinoma Using the Miyazaki Urological Cancer Database (MUCD)

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: October 06, 2021

A case of von Hippel-Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy.

A case of von Hippel-Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy.

Journal: Urology case reports

Published: September 30, 2021

A Case of Stauffer Syndrome-Like Findings Associated with Metastatic Renal Cell Cancer Improved by Molecular Targeted Therapy

A Case of Stauffer Syndrome-Like Findings Associated with Metastatic Renal Cell Cancer Improved by Molecular Targeted Therapy

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: August 06, 2021

A Case of Neuroendcrine Carcinoma of the Prostate Diagnosed by Prostate Re-Biopsy during Hormonal Treatment and Effectively Treated by Multidisciplinary Therapy

A Case of Neuroendcrine Carcinoma of the Prostate Diagnosed by Prostate Re-Biopsy during Hormonal Treatment and Effectively Treated by Multidisciplinary Therapy

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: April 23, 2020

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis.

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis.

Journal: Research and reports in urology

Published: December 25, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026